Dimercaprol
Severe
Database
Clinical effect not specified
Source: DDInter
Drug reference
ferumoxytol
Parenteral Iron Supplement · Antianemic
Parenteral Iron SupplementAntianemic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactions
- DimercaprolSevereDatabaseDDInter
Mechanism
Not yet extracted
Indications
iron deficiency anemia in patients with chronic kidney diseaseiron deficiency anemia in adults with an intolerance or unsatisfactory response to oral iron
Dosing
- Adult
- Single dose of 1020 mg, or two doses of 510 mg, given 3–8 days apart. Administered over at least 15 min (30 min for 1020-mg dose).
Side effects
Serious
- hypersensitivity reactions
Drug interactions
11 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Chronic kidney disease — assessment and management
KDIGO · Nephrology · 2024
Iron deficiency anaemia in pregnancy
ICMR · Obstetrics & Gynaecology · 2022
Iron deficiency anaemia in adults
ICMR · Hematology · 2023
Chronic kidney disease — assessment and management
NICE · Nephrology · 2021
Diabetes management in chronic kidney disease
KDIGO · Nephrology · 2022
Other Parenteral Iron Supplement drugs
Ask House about ferumoxytol
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team